217 related articles for article (PubMed ID: 1531453)
21. The role of antibody isotype in IFN-gamma and IL-2 production during anti-CD3-induced T cell proliferation.
Frenken LA; Koene RA; Tax WJ
Transplantation; 1991 Apr; 51(4):881-7. PubMed ID: 1826571
[TBL] [Abstract][Full Text] [Related]
22. Activation via the CD3 and CD16 pathway mediates interleukin-2-dependent autocrine proliferation of granular lymphocytes in patients with granular lymphocyte proliferative disorders.
Hoshino S; Oshimi K; Teramura M; Mizoguchi H
Blood; 1991 Dec; 78(12):3232-40. PubMed ID: 1835892
[TBL] [Abstract][Full Text] [Related]
23. Anti-CD3 monoclonal antibody therapy. An approach toward optimization by in vitro analysis of new anti-CD3 antibodies.
Woodle ES; Thistlethwaite JR; Jolliffe LK; Fucello AJ; Stuart FP; Bluestone JA
Transplantation; 1991 Aug; 52(2):361-8. PubMed ID: 1714644
[TBL] [Abstract][Full Text] [Related]
24. T cell proliferative response to interleukin 2: different frequency of responders among CD45R0 and CD45RA subsets.
Chinn A; Cosyns M; Hayward AR
Cell Immunol; 1990 Nov; 131(1):132-9. PubMed ID: 2146031
[TBL] [Abstract][Full Text] [Related]
25. The anti-T cell monoclonal antibody 9.3 (anti-CD28) provides a helper signal and bypasses the need for accessory cells in T cell activation with immobilized anti-CD3 and mitogens.
Baroja ML; Lorre K; Van Vaeck F; Ceuppens JL
Cell Immunol; 1989 Apr; 120(1):205-17. PubMed ID: 2539266
[TBL] [Abstract][Full Text] [Related]
26. Induction of T cell proliferation with anti-CD3 switch-variant monoclonal antibodies: effects of heavy chain isotype in monocyte-dependent systems.
Van Lier RA; Boot JH; De Groot ER; Aarden LA
Eur J Immunol; 1987 Nov; 17(11):1599-604. PubMed ID: 2960543
[TBL] [Abstract][Full Text] [Related]
27. IL-2-R beta expression and function within resting CD8+ T cells preferentially segregate with the CD45R0+ subset.
Moire N; Rouleau M; Metivier D; Charpentier B; Senik A
Eur Cytokine Netw; 1991; 2(5):319-27. PubMed ID: 1839506
[TBL] [Abstract][Full Text] [Related]
28. Human CD8+ T lymphocytes can be divided into CD45RA+ and CD45RO+ cells with different requirements for activation and differentiation.
de Jong R; Brouwer M; Miedema F; van Lier RA
J Immunol; 1991 Apr; 146(7):2088-94. PubMed ID: 1826015
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory effects of anti-CD2 monoclonal antibodies on interleukin 2 production and interleukin 2 receptor expression in anti-CD3-induced T cell activation.
Stohl W; Linker-Israeli M
Cell Immunol; 1989 May; 120(2):351-65. PubMed ID: 2566387
[TBL] [Abstract][Full Text] [Related]
30. Preferential activation of CD45RA+ cells by a monoclonal antibody to the alpha/beta T-cell receptor.
Schwinzer R; Schlitt HJ; Wonigeit K
Transplant Proc; 1991 Feb; 23(1 Pt 1):277-8. PubMed ID: 1824983
[No Abstract] [Full Text] [Related]
31. Monocyte-independent interleukin-2 production and proliferation of human T cells in response to murine hybridomas expressing the OKT3 monoclonal antibody: interleukin-1 is not required for T-cell proliferation.
Itoh K; Balch CM; Platsoucas CD
Cell Immunol; 1988 Aug; 115(1):36-56. PubMed ID: 2969776
[TBL] [Abstract][Full Text] [Related]
32. Differential effects of CD45 CD45R and CD45R0 monoclonal antibodies in modulating human B cell activation.
Deane DL; Harvey E; Steel CM
Clin Exp Immunol; 1991 Jan; 83(1):175-81. PubMed ID: 1703055
[TBL] [Abstract][Full Text] [Related]
33. CD4+ CD45RA+ T cells modulate allergen-induced interleukin 2 responsiveness in human lymphocytes.
Kawano Y; Noma T; Maeda K; Yata J
Clin Immunol Immunopathol; 1992 Mar; 62(3):327-35. PubMed ID: 1531787
[TBL] [Abstract][Full Text] [Related]
34. Differential activation of p21ras in CD45RA+ and CD45RO+ human T lymphocytes.
Patel HR; Renz H; Terada N; Gelfand EW
J Immunol; 1994 Mar; 152(6):2830-6. PubMed ID: 8144884
[TBL] [Abstract][Full Text] [Related]
35. Induction of suppressor cells to T- and B-cell proliferative responses and immunoglobulin production by monoclonal antibodies recognizing the CD3 T-cell differentiation antigen.
Kunicka JE; Platsoucas CD
Cell Immunol; 1988 Oct; 116(1):195-215. PubMed ID: 2901914
[TBL] [Abstract][Full Text] [Related]
36. T cell activation by monoclonal antibodies directed to different epitopes on the human T cell receptor/CD3 complex: evidence for two different modes of activation.
Schlitt HJ; Kurrle R; Wonigeit K
Eur J Immunol; 1989 Sep; 19(9):1649-55. PubMed ID: 2477253
[TBL] [Abstract][Full Text] [Related]
37. Regulation by anti-CD2 monoclonal antibody of the activation of a human T cell clone induced by anti-CD3 or anti-T cell receptor antibodies.
Yssel H; Aubry JP; de Waal Malefijt R; de Vries JE; Spits H
J Immunol; 1987 Nov; 139(9):2850-5. PubMed ID: 2444643
[TBL] [Abstract][Full Text] [Related]
38. The effect of the CD28 activation pathway on the immunosuppressive action of cyclosporine.
Hess AD; Bright EC
Transplantation; 1991 Jun; 51(6):1232-40. PubMed ID: 1646506
[TBL] [Abstract][Full Text] [Related]
39. B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2.
Gimmi CD; Freeman GJ; Gribben JG; Sugita K; Freedman AS; Morimoto C; Nadler LM
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6575-9. PubMed ID: 1650475
[TBL] [Abstract][Full Text] [Related]
40. Activation of human T cells in vivo following treatment of transplant recipients with OKT3.
Ellenhorn JD; Woodle ES; Ghobreal I; Thistlethwaite JR; Bluestone JA
Transplantation; 1990 Oct; 50(4):608-12. PubMed ID: 2145669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
